Up next

Autoplay

A Third of Patients Abandon Breast Cancer Drug Due to Side Effects

0 Views • 08/17/25
Share
Side Effects
Side Effects
Subscribers
0

Over a third of post-menopausal breast cancer patients who take aromatase inhibitors abandon their treatment, because the drug's side effects are so unbearable, according to researchers from Northwestern University. Aromatase inhibitors are typically given to patients following chemotherapy, radiation therapy, and breast cancer surgery, usually for about 5 years.

Show more
0 Comments sort Sort By

Up next

Autoplay